Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vical Inc (NASDAQ:VICL)

0.644
Delayed Data
As of Jul 31
 +0.014 / +2.22%
Today’s Change
0.60
Today|||52-Week Range
1.55
-38.67%
Year-to-Date
No recent news for Vical Inc.

Today’s Trading

Previous close0.63
Today’s open0.63
Day’s range0.61 - 0.65
Volume160,277
Average volume (3 months)1,163,430
Market cap$58.9M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+47.22%
Earnings growth (this year)+12.28%
Earnings growth (next 5 years)--
Revenue growth (last year)+97.16%
P/E ratioNM
Price/Sales6.13
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
VKTXViking Therapeutics ...-0.33-5.14%
PRANPrana Biotechnology ...-0.01-0.85%
ENZNEnzon Pharmaceutical...-0.01-0.72%
ADMPAdamis Pharmaceutica...+0.05+1.26%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$15.2M
Annual profit (last year)-$16.5M
Net profit margin-108.38%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Vijay B. Samant
Vice President-
Vaccine Research
Larry Russell Smith
Corporate headquarters
San Diego, California

Forecasts